(Q35842612)

10 August 2017

1 reference

title

Using antibodies in tumour immunotherapy (English)

1 reference

10 August 2017

1 reference

Birgit C Schultes

1

1 reference

10 August 2017

Christopher F Nicodemus

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

number of pages

20

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

1265-1284

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Dominance and crypticity of T cell antigenic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Mechanisms of antigen uptake for presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Cross-presentation, dendritic cells, tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Capture and processing of exogenous antigens for presentation on MHC molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Idiotypic immunization induces immunity to mutated p53 and tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Generation of CD4(+) and CD8(+) T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Immunodominance and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Human anti-idiotypic antibodies induced a humoral and cellular immune response against a colorectal carcinoma-associated antigen in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Mechanisms of interleukin-10-mediated immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Targeting the TGF beta signaling network in human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Regulatory T cells in autoimmmunity*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Regulatory T cells under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

CD4(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

T cell costimulatory pathways: blockade for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

The TRAIL to selective tumor death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

CTLA-4: new insights into its biological function and use in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

CTLA-4: a negative regulator of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Activation of the PKB/AKT pathway by ICAM-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

VEGF as a mediator of tumor-associated immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

Antigen-specific interaction between T and B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.8.1265

10.1517/14712598.4.8.1265

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference